Drug intelligence / Profile preview

epigallocatechin-3-gallate + quercetin + rutin

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

A combination of three polyphenolic compounds — **epigallocatechin-3-gallate (EGCG)**, **quercetin**, and **rutin**. This combination, often referred to as EQR, has been studied primarily as a functional ingredient for metabolic health and obesity management. EQR exhibits *anti-obesity*, *antioxidant*, and *gut microbiota-modulatory* effects in preclinical (animal) models. It reduces body and adipose tissue weight, decreases liver lipid accumulation, enhances fatty acid oxidation and thermogenesis, and suppresses lipid synthesis and transport. EQR treatment also beneficially modifies gut microbiota composition and increases fecal short-chain fatty acid levels. EGCG, quercetin, and rutin are natural flavonoids/polypenols with reported antioxidative, anti-inflammatory, and metabolic effects. Preliminary mechanistic studies suggest this combination regulates gene expression related to lipid metabolism (PPAR-α upregulation, PPAR-γ downregulation, SIRT-1, PGC-1α) and can enhance certain beneficial bacterial taxa in the gut[2].

Other names
EQR
02

Targets

SARS-CoV-2 spikePPARA (Peroxisome proliferator-activated receptor alpha)PNLIP (Pancreatic triacylglycerol lipase)PPARG (Peroxisome proliferator-activated receptor gamma)SIRT1 (NAD-dependent protein deacetylase sirtuin-1)Nsp15 (SARS-CoV-2 non-structural protein 15)

Beyond the preview

Go deeper on epigallocatechin-3-gallate + quercetin + rutin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on epigallocatechin-3-gallate + quercetin + rutin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call